Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working.

Similar presentations


Presentation on theme: "Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working."— Presentation transcript:

1 Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working Group Study  Yoshihiro Inamoto, Fumihiko Kimura, MD, PhD, Junya Kanda, MD, Junichi Sugita, MD, PhD, Kazuhiro Ikegame, MD, PhD, Hideki Nakasone, MD, PhD, Yasuhito Nannya, MD, PhD, Naoyuki Uchida, MD, PhD, Takahiro Fukuda, M.D, PhD, Kosuke Yoshioka, MD, Yukiyasu Ozawa, MD PhD, Ichiro Kawano, MD, Yoshiko Atsuta, PhD, Koji Kato, MD, PhD, Tatsuo Ichinohe, MD, PhD, Masami Inoue, MD, Takanori Teshima, MD, PhD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S399-S400 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Biology of Blood and Marrow Transplantation 2016 22, S399-S400DOI: (10
Biology of Blood and Marrow Transplantation  , S399-S400DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working."

Similar presentations


Ads by Google